NASDAQ:SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. reported net income of −$11.7M in fiscal 2025. The diluted share count rose 1318.2%.Summary generated from Shuttle Pharmaceuticals Holdings, Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−791.0%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+1318.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −2 | −2 | −6 | −8 | −12 |
| Net income | −1 | −5 | −7 | −9 | −12 |
| Free cash flow | n/a | n/a | −6 | n/a | n/a |
Recent filings
- 10-QQuarterly report for the period ended Jun 30, 2026
Sep 24, 2026 - 8-K/AAmended current report
Sep 24, 2026 - 8-KCurrent report
Sep 16, 2026 - 8-KResults of a shareholder vote
Sep 11, 2026 - 8-KOther events
Sep 2, 2026 - 8-KEntry into a material agreement
Sep 1, 2026 - 8-KNotice of delisting or listing-rule failure
Aug 28, 2026 - 8-K/AAmended completion of an acquisition or disposition
Aug 17, 2026